• Ibrexafungerp (MK 3118): Overcoming Antifungal Resistance in

  2026-05-25

  Discover how Ibrexafungerp (MK 3118) advances antifungal therapy by maintaining potent activity against resistant Candida in acidic environments. This in-depth analysis explores unique assay evidence and practical implications for translational research.

• Selective Nuclear Export Inhibition Enhances Cas9 Genome Edi

  2026-05-24

  The reference study demonstrates that the FDA-approved drug KPT330 and related SINE compounds improve the specificity of CRISPR-Cas9 genome and base editing by indirectly inhibiting Cas9 activity via selective regulation of mRNA nuclear export. This approach introduces a new class of small-molecule modulators that expand the CRISPR genome engineering toolkit, with implications for reducing off-target effects in mammalian genome editing.

• Rapamycin (Sirolimus) in Lipid Autophagy and Metabolic Stres

  2026-05-23

  Explore how Rapamycin (Sirolimus) extends beyond mTOR inhibition to modulate autophagy and lipid metabolism, with unique insights for metabolic disease and aquaculture research. This article synthesizes the latest mechanistic evidence and practical guidance for advanced biomedical workflows.

• Reliable Assays with Coagulation Factor II (Thrombin) B Chai

  2026-05-22

  This evidence-driven article addresses key experimental challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (SKU A1057) ensures reproducible, high-fidelity data. Integrating real-world laboratory scenarios, we outline protocol parameters, scientific rationale, and comparative insights to support optimal reagent selection and workflow design.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Workflow

  2026-05-22

  Cy3 NHS ester (non-sulfonated) is a practical fluorescent dye for labeling primary amines in proteins, peptides, and oligonucleotides, offering robust orange fluorescence at 555/570 nm. It is ideal for protocols that can tolerate organic co-solvents, but not recommended for applications requiring aqueous-only labeling conditions or long-term storage in solution.

• BX795: Strategic Advances in Cancer and Immune Pathway Modul

  2026-05-21

  Explore how BX795, a selective PDK1 inhibitor, is reshaping translational research by bridging mechanistic insight and practical workflow for cancer and innate immune studies. This article synthesizes emerging in vitro evaluation strategies, comparative kinase inhibitor intelligence, and actionable protocol guidance—escalating the discussion beyond routine product profiles to offer real-world value for translational scientists.

• Cell Cycle Assay Kit (K2263): Deciphering Cell Cycle Dynamic

  2026-05-21

  Explore how the Cell Cycle Assay Kit empowers precise cell cycle phases G0/G1, S, and G2/M analysis, enabling advanced apoptosis detection and translational cancer research. This article unveils unique assay insights and connects recent molecular findings to practical protocol optimization.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-05-20

  Mdivi-1 empowers researchers to dissect mitochondrial fission and apoptosis with high specificity, enabling advanced neuroprotection and metabolism studies. This guide translates the latest microbiome-apoptosis insights and practical troubleshooting into actionable protocols for reproducible mitochondrial dynamics research.

• Acifran (SKU B6848): Reliable Agonist for Lipid Metabolism R

  2026-05-20

  This article details how Acifran (SKU B6848), a selective HM74A/GPR109A and GPR109B agonist, addresses real-world challenges in cell-based lipid metabolism studies. Scenario-driven discussion highlights evidence-backed workflow improvements, protocol optimization, and vendor reliability for biomedical researchers using Acifran in signaling pathway and metabolic disorder research.

• Dasatinib (BMS-354825): Mechanistic and Strategic Guidance f

  2026-05-19

  Explore how Dasatinib (BMS-354825) empowers translational researchers to probe kinase-driven malignancies, with a focus on mechanistic insights from EMT and stemness signaling. This article bridges recent findings on the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors with practical experimental strategies, benchmarking APExBIO’s Dasatinib for cutting-edge translational research.

• Griseofulvin: Microtubule Associated Inhibitor in Antifungal

  2026-05-19

  Griseofulvin enables precise disruption of microtubule dynamics, making it indispensable for advanced antifungal assays and aneugenicity profiling. Explore actionable workflows, troubleshooting strategies, and key innovations that set APExBIO’s Griseofulvin apart in microtubule-targeted research.

• EdU Imaging Kits (488): Precision 5-ethynyl-2'-deoxyuridine

  2026-05-18

  EdU Imaging Kits (488) enable rapid, reliable S-phase DNA synthesis measurement with superior sensitivity and minimal cell disruption. Streamline your cell proliferation assays for advanced applications in stem cell, cancer, and regenerative medicine research—backed by APExBIO's proven workflow consistency.

• Acid-Responsive Polymers Boost RNA Release from Lipid Nanopa

  2026-05-18

  Cheung et al. report that incorporating acid-responsive poly(lactic acid)-block-poly(carboxybetaine) derivatives into lipid nanoparticles enables pH-triggered RNA release and enhances transfection efficiency in mammalian cells. This approach improves cytosolic delivery of siRNA and mRNA without increasing cytotoxicity, offering a promising strategy for advancing RNA therapeutics and reporter assays.

• U0126-EtOH: Precision MEK1/2 Inhibition for Neuroprotection

  2026-05-17

  Explore the unique capabilities of U0126-EtOH as a highly selective MEK1/2 inhibitor for advanced neuroprotection and mechanistic paraptosis research. This article provides nuanced analysis, protocol guidance, and integrates the latest MAPK pathway insights for oxidative stress assays.

• Salinomycin: Polyether Ionophore Antibiotic in HCC Research

  2026-05-16

  Salinomycin empowers cancer biologists with a multi-modal mechanism—targeting ABC drug transporters and the Wnt/β-catenin pathway—to induce apoptosis in hepatocellular carcinoma cells. This guide highlights practical workflows, troubleshooting strategies, and actionable protocols, setting Salinomycin apart as an advanced research tool from APExBIO.

14848 records 4/990 page Previous Next 12345 下5页 Last page